Today: 29 June 2026
Browse Category

NASDAQ:PSTV 26 September 2025 - 25 November 2025

PSTV Stock on November 25, 2025: FDA Meeting, Nasdaq Extension and Humana Deal Put Plus Therapeutics Back in Focus

PSTV Stock on November 25, 2025: FDA Meeting, Nasdaq Extension and Humana Deal Put Plus Therapeutics Back in Focus

As traders log in on Tuesday, November 25, 2025, Plus Therapeutics is back on the radar thanks to a cluster of late‑November catalysts: an FDA Type B meeting for lead radiotherapeutic REYOBIQ™, a fresh 180‑day Nasdaq bid‑price extension, and a national coverage agreement with Humana for its CNSide® cancer diagnostic. As of the latest completed trading session on Monday, November 24, PSTV last changed hands at $0.5752, up roughly 8% on the day, after trading between $0.50 and $0.59 on volume of about 8.4 million shares. Even after that bounce, the stock still sits well below its 52‑week high of $2.31 and above its 52‑week low of $0.16, underscoring how volatile this micro‑cap biotech has been over the past year.MarketBeat
25 November 2025
·
PSTV ERUPTS: UnitedHealthcare Backs Plus Therapeutics’ CNS Cancer Test—Stock Pops, Analysts Cheer, and the Real Winners Could Be Patients

PSTV ERUPTS: UnitedHealthcare Backs Plus Therapeutics’ CNS Cancer Test—Stock Pops, Analysts Cheer, and the Real Winners Could Be Patients

Key facts UnitedHealthcare coverage win. On Sept. 25, Plus Therapeutics announced that UnitedHealthcare Insurance Company granted national coverage for its CNSide® CSF Tumor Cell Enumeration LDT for metastatic CNS cancer, effective Sept. 15. The deal potentially opens access to more than 51 million members nationwide and positions CNSide as a covered testing service for specialists treating leptomeningeal metastases—a devastating complication of advanced cancers. GlobeNewswire
26 September 2025
···

Stock Market Today

  • Crude climbs as Strait of Hormuz shipping slows, US-Iran ease off attacks
    June 29, 2026, 1:51 PM EDT. Crude oil traded higher with tanker flow through the Strait of Hormuz slowing while US-Iran tensions stayed in focus. August WTI rose 1.78%, helped by a weaker dollar and firmer equities. The US and Iran agreed today to freeze attacks, which pulled crude back from session highs. Flows through the Strait recently pushed exports up to 75% of pre-war rates, but Iraq's threat to leave OPEC and the IEA demand warning kept some pressure on prices. US supply forecasts stayed strong. Ukrainian drone hits on Russian oil facilities are still cutting Russian crude processing to levels not seen in two decades, as Western sanctions keep squeezing exports.
Go toTop